Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 2/20 | 0.57 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.57 |
| ▸ | MAOA | P21397 | 2/20 | 0.57 |
| ▸ | MAOB | P27338 | 2/20 | 0.57 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.50 |
| ▸ | HTR2A | P28223 | 1/20 | 0.50 |
| ▸ | PPARG | P37231 | 1/20 | 0.49 |
| ▸ | PPARA | Q07869 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29400447 | 1.00 | LPL (0.57) | LPLLIPGMAOAMAOBCYP19A1 | |
| SCHEMBL29400049 | 1.00 | LPL (0.57) | LPLLIPGMAOAMAOBCYP19A1 | |
| SCHEMBL28489702 | 1.00 | LPL (0.57) | LPLLIPGMAOAMAOBCYP19A1 | |
| SCHEMBL29598219 | 1.00 | LPL (0.57) | LPLLIPGMAOAMAOBCYP19A1 | |
| SCHEMBL6628922 | 1.00 | LPL (0.57) | LPLLIPGMAOAMAOBCYP19A1 | |
| SCHEMBL28501541 | 1.00 | LPL (0.57) | LPLLIPGMAOAMAOBCYP19A1 | |
| SCHEMBL352479 | 1.00 | LPL (0.57) | LPLLIPGMAOAMAOBCYP19A1 | |
| SCHEMBL3625874 | 1.00 | LPL (0.57) | LPLLIPGMAOAMAOBCYP19A1 | |
| SCHEMBL16236477 | 1.00 | LPL (0.57) | LPLLIPGMAOAMAOBCYP19A1 | |
| SCHEMBL28493034 | 1.00 | LPL (0.57) | LPLLIPGMAOAMAOBCYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5446189-A | Diester intermediates for diacid enzyme inhibitor | HOFFMANN-LA ROCHE INC. (US) | 1995-08-29 | — | — | US | disclosed |
| US-5324747-A | Treatment of inflammatory diseases | HOFFMANN-LA ROCHE INC. (US) | 1994-06-28 | — | — | US | disclosed |
| EP-0579066-A2 | N-substituted anilines | F. HOFFMANN-LA ROCHE AG (CH) | 1994-01-19 | — | — | EP | disclosed |